biosimilars

Three years after approval, court blocks US launch of Enbrel biosimilar

https://pharmaphorum.com/news/three-years-after-approval-court-blocks-us-launch-of-enbrel-biosimilar/

Roche under pressure in US as Amgen/Allergan launch US cancer biosimilars

https://pharmaphorum.com/news/roche-under-pressure-in-us-as-amgen-allergan-launch-us-cancer-biosimilars/

10 Key Reasons to attend SMi’s 10th Annual Biosimilars Conference

https://pharmaphorum.com/partner-content/10-key-reasons-to-attend-smis-10th-annual-biosimilars-conference/

Drug Delivery & Formulation Summit 2019

https://pharmaphorum.com/events/drug-delivery-formulation-summit-2019/

Exclusive Interview with ASBM Released Ahead of Upcoming Biosimilars Conference

https://pharmaphorum.com/partner-content/exclusive-interview-with-asbm-released-ahead-of-upcoming-biosimilars-conference/

Optimising market access for biosimilars

https://pharmaphorum.com/views-analysis-market-access/optimising-market-access-for-biosimilars/

Nine for 2019: Opportunities for pharma

https://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/

Michel Mikhail invites Biosimilar experts to attend SMi’s 10th Annual Biosimilars

https://pharmaphorum.com/partner-content/michel-mikhail-invites-biosimilar-experts-to-attend-smis-10th-annual-biosimilars/

Sandoz strikes deal with EirGenix for Herceptin biosimilar

https://pharmaphorum.com/news/sandoz-strikes-deal-with-eirgenix-for-herceptin-biosimilar/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search